SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Judy Muldawer who wrote (2771)5/14/1997 9:21:00 PM
From: John H. Farro   of 4342
 
Judy, I am also somewhat sceptical about them launching AndroVir before September. You wrote:

>Product delay is because when they release it, they want to make sure >it is done correctly.

This is quite different from their press release of a few weeks ago stating that they were re-evaluating the product. If they are telling the truth now then it is unlikely that the delay was caused by the FDA or by serious doubts about the product as implied by the press release. I think it is likely that they were either lying in their original press release or they are lying now through their PR agent to get the stockholders off their backs. Let's assume they are telling the truth now and that they intend to launch AndroVir by September. They said they want to do it correctly. Is it necessary for them to hire some officers in order for them to launch it correctly? If this is a prerequisite then they are in real trouble because I doubt anyone with the proper experience would want to join the company. Or do they think they can launch AndroVir correctly with their current staffing level?

Robin
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext